1-15 of 15
managed care programs
Close
Sort by
Journal Articles

Patient Adherence and Persistence to Oral Targeted Therapies for Hematologic Malignancies: A Retrospective Cohort Study Among Managed Care Enrollees

Krish Patel, MD, Vinjamuri Sai Sudhir, Shaum Kabadi, PhD MPH, Joanna C Huang, PharmD, Sanchita Porwal, BS, Kushan Thakkar, MS, John M. Pagel, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3534.
https://doi.org/10.1182/blood-2018-99-112820
Published: 2018
Journal Articles

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Smith Giri, MBBS, Valerie Shostrom, MS, Krishna Gundabolu, MD, KM Monirul Islam, MDPhD, Ranjan Pathak, MD, Lori J. Maness, MD, Vijaya R. Bhatt, MD
Journal: Blood
Blood (2015) 126 (23): 533.
https://doi.org/10.1182/blood.V126.23.533.533
Published: 2015
Journal Articles

Evaluation of Comorbidities Relevant to Tyrosine Kinase Inhibitor Treatment Among Patients with Chronic Myelogenous Leukemia in the U.S. Managed Care Setting

Elias Jabbour, MD, Dinara Makenbaeva, MD MBA, Melissa Lingohr-Smith, PhD, Jay Lin, PhD MBA
Journal: Blood
Blood (2014) 124 (21): 4550.
https://doi.org/10.1182/blood.V124.21.4550.4550
Published: 2014
Journal Articles

Type of Bleeding Among Patients with Nonvalvular Atrial Fibrillation in a Large Managed Care Population

Steven Deitelzweig, MD, Brett Pinsky, MPH, Erin Buysman, MS, Michael Lacey, MSc, Dinara Makenbaeva, MD, MBA, Daniel Wiederkehr, John Graham, PharmD
Journal: Blood
Blood (2012) 120 (21): 2073.
https://doi.org/10.1182/blood.V120.21.2073.2073
Published: 2012
Journal Articles

Analysis of the Impact and Burden of Illness of Polycythemia Vera (PV) and Essential Thrombocythemia (ET) in the US

Jyotsna Mehta, Hongwei Wang, Usman Iqbal, Ruben A. Mesa
Journal: Blood
Blood (2012) 120 (21): 2071.
https://doi.org/10.1182/blood.V120.21.2071.2071
Published: 2012
Journal Articles

Association Between Age and Bleeding Events of Different Severities Among Patients with Nonvalvular Atrial Fibrillation in a Managed Care Population

Steven Deitelzweig, MD, Brett Pinsky, Erin Buysman, MS, Michael Lacey, MSc, Yonghua Jing, PhD, Daniel Wiederkehr, John Graham, PharmD
Journal: Blood
Blood (2012) 120 (21): 4238.
https://doi.org/10.1182/blood.V120.21.4238.4238
Published: 2012
Journal Articles

Retrospective Database Analysis of the Effect of Zoledronic Acid (ZOL) On Skeletal-Related Events (SREs) in Patients (Patients) with Multiple Myeloma (MM).

Henry J Henk, PhD, Satyin Kaura, Jose Ricardo Perez, Laura Becker
Journal: Blood
Blood (2009) 114 (22): 3881.
https://doi.org/10.1182/blood.V114.22.3881.3881
Published: 2009
Journal Articles

Retrospective Database Analysis of Patterns of Zoledronic Acid (ZOL) Treatment in Patients with Multiple Myeloma (MM) and Malignant Bone Lesions (BM).

Donna Spencer, Satyin Kaura, Jose Ricardo Perez, Henry J Henk, PhD
Journal: Blood
Blood (2009) 114 (22): 4944.
https://doi.org/10.1182/blood.V114.22.4944.4944
Published: 2009
Journal Articles

Medical Visit Patterns in Cancer Chemotherapy Patients Receiving Erythropoiesis-Stimulating Agents in a Managed Care Setting.

Scott R. McKenzie, MD, Patrick Lefebvre, MA, Brahim K. Bookhart, MBA, MPH, François Laliberté, MA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2007) 110 (11): 5156.
https://doi.org/10.1182/blood.V110.11.5156.5156
Published: 2007
Journal Articles

Drug Utilization Patterns and Cost Considerations for Erythropoiesis Stimulating Agents in Cancer Chemotherapy Patients in a Managed Care Setting.

Alyson Mandel, PhD, Richard Weininger, MD, Scott R. McKenzie, MD, Brahim K. Bookhart, MBA, MPH, Catherine T. Piech, MBA
Journal: Blood
Blood (2007) 110 (11): 5157.
https://doi.org/10.1182/blood.V110.11.5157.5157
Published: 2007
Journal Articles

A Budget Impact Model Comparing Resource Utilization of Four Approved Therapies for Multiple Myeloma (MM) in the US.

D.S. Pete Fullerton, Holly Trautman, Hui Huang, Jelena Veljkovic, Dixie-Lee Esseltine, Jing Marantz
Journal: Blood
Blood (2007) 110 (11): 3324.
https://doi.org/10.1182/blood.V110.11.3324.3324
Published: 2007
Journal Articles

The Clinical and Direct Medical Cost Burden of Splenectomy among Managed Care Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Louis M. Aledort, Roger M. Lyons, Gary Okano, Joseph Leveque
Journal: Blood
Blood (2006) 108 (11): 5536.
https://doi.org/10.1182/blood.V108.11.5536.5536
Published: 2006
Journal Articles

A Retrospective Study of Current Anticoagulant Use in Patients with Atrial Fibrillation: Results from a Managed Care Database.

Miranda Murray, PhD, Howard Friedman, PhD
Journal: Blood
Blood (2005) 106 (11): 2246.
https://doi.org/10.1182/blood.V106.11.2246.2246
Published: 2005
Journal Articles

Variability in Measures of Health Outcomes in Sickle Cell Disease (SCD) Patients with Access to Comprehensive Care Centers.

Sadhna M. Shankar, MD, MPH, Patrick Abrogast, Ph.D, Ed Mitchel, MS, Hua Ding, MS, Winfred Wang, MD, Marie R. Griffin, MD, MPH
Journal: Blood
Blood (2005) 106 (11): 294.
https://doi.org/10.1182/blood.V106.11.294.294
Published: 2005
Journal Articles

An Evaluation of the Impact of Recurrent Venous Thromboembolic Disease and Hemorrhagic Events within the Managed Care Setting.

Caron Ory, R.N., M.S.N., Lori Cyprien, M.S., Jennifer Kim, Pharm.D., Ole Hauch, M.D., Eunice Chang, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2207.
https://doi.org/10.1182/blood.V104.11.2207.2207
Published: 2004